About this trial

Women with Polycystic Ovary Syndrome (PCOS) have high testosterone levels which is associated with altered insulin-glucose metabolism and an adverse blood lipid profile, predisposing them to the development of Type II Diabetes and Cardiovascular Disease (CVD). This study will investigate the use of dietary fish oil supplementation as a safe and effective intervention, and as an adjunct therapy to standard of care treatment with metformin to improve heart health, blood lipids and insulin-glucose metabolism in women with PCOS, and those with PCOS and Type 2 Diabetes.

Eligibility criteria

Qualifiers

diagnosis of PCOS

overweight-obese (BMI >25 kg/m2)

elevated fasting plasma TG (>150 mg/dL)

and/or apoB48-remnant cholesterol lipoproteins (>20 ug/ml)

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Fish oil
  • Metformin
  • Fish Oil and Metformin

Treatment groups

146 Participants
are divided into 2 treatment groups

Locations

3
Human Nutrition Research Unit - Li Ka Shing Health Research CenterT6G 2E1, EdmontonAlberta, Canada
Mazankowski Alberta Heart InstituteT6G-2B7, EdmontonAlberta, Canada
University of Alberta Hospital - Division of EndocrinologyT6G-2B7, EdmontonAlberta, Canada

Sponsors and collaborators

University of Alberta

Lead sponsor

Heart and Stroke Foundation of Canada

Collaborator